Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mark A Hallman

3PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413.

|Dec 01, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Sebastian Medina, Naoto Tokuyama, Kamal Hammouda

|Dec 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).

Daniel M Geynisman, Philip H Abbosh, Eric Ross

Pageof 1

Frequent Collaborators

2 joint publications

Stephanie L Pugh

1 joint publications

Daniel M Geynisman

1 joint publications

Philip H Abbosh

1 joint publications

Eric Ross

1 joint publications

Matthew R Zibelman

1 joint publications

James R Mark

1 joint publications

Jean H Hoffman-Censits

1 joint publications

Richard E Greenberg

1 joint publications

Eric M Horwitz

1 joint publications

David Y T Chen

Frequent Collaborators

2 joint publications

Stephanie L Pugh

1 joint publications

Daniel M Geynisman

1 joint publications

Philip H Abbosh

1 joint publications

Eric Ross